Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. …
Read More
CHEYNEY, PA — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announced the opening of its R&D operations at the Cheyney University science center …
Read More
Late summer/early fall is the height of ragweed season. When you add in exposure to environmental factors found in school classrooms, playing fields and eating areas, you have the perfect …
Read More
April showers may bring May flowers, but they also bring sneezing, congestion, and runny noses for millions of people who suffer from springtime allergies. Tower Health Urgent Care is here …
Read More
EXTON, PA — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for the treatment of cancer, is providing an update on …
Read More
MALVERN, PA — Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a clinical-stage biopharmaceutical company focused on developing novel therapeutics in immune-mediated diseases, announced the publication of a pre-clinical study …
Read More